Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.12% | -0.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.56% | 5.11% | |||
| Operating Income | 18.56% | -5.11% | |||
| Income Before Tax | 18.35% | -4.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.35% | -4.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.35% | -4.95% | |||
| EBIT | 18.56% | -5.11% | |||
| EBITDA | 18.36% | -5.19% | |||
| EPS Basic | 28.07% | 58.08% | |||
| Normalized Basic EPS | 28.06% | 58.08% | |||
| EPS Diluted | 28.07% | 58.08% | |||
| Normalized Diluted EPS | 28.06% | 58.08% | |||
| Average Basic Shares Outstanding | 13.51% | 150.38% | |||
| Average Diluted Shares Outstanding | 13.51% | 150.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||